New Sales and Marketing Director in Denomega

O'Shea joins Denomega from Borregaard’s fine chemical business, where he was Vice President of Sales, Marketing & New Business Development. He has more than 20 years of international experience towards the pharmaceutical industry.

22 Sep 2009 --- Denomega Nutritional Oils, a supplier of taste and odor free Omega-3 solutions for the food and supplement markets, have announced the appointment of Mike O'Shea as the new Director of Sales and Marketing. In his new role Mike O'Shea  will be responsible for managing all sales and marketing activities in Denomega. O'Shea joins Denomega from Borregaard’s fine chemical business,  where he was Vice President of Sales, Marketing & New Business Development. He has more than 20 years of international experience towards the pharmaceutical industry, which demands extremely high standards of customer service and product quality. His previous roles include that as Managing Director of Borregaard UK Limited. O'Shea holds a BSc in Chemistry from Cardiff University  and an MBA from Henley Business School in the UK.

“Denomega clearly has an impressive profile, which combines a long history of fish oil refining with a very competent and dynamic team.  I am really looking forward to the challenge of further developing the good reputation which the company has built internationally  during recent years”, says Mike O'Shea. As Denomega continues to develop and solidify its position as the leading supplier  of taste and odor free Omega-3, I now look forward to developing a winning team to deliver the company’s ambitious plans for future growth”,  O'Shea continues.

Denomega is growing and developing in a very interesting and dynamic market, and I am very pleased to have Mike O’Shea onboard”, says Managing Director Dr. Harald Ronneberg. "We are producing and selling premium health promoting Omega-3 to important markets in USA, Europe and Asia. We expect a great contribution from Mike O’Shea with his international experience in pharmaceutical and health industry".